Skip to main content

Table 1 Year of publication, journal and country of birth or study of patients with anti-NMDAR encephalitis and ovarian teratoma

From: Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases

1A. Year of publication (number of papers) Number of cases %
Before/or in 2006 (13) 16 9,2
2007 (6) 14 8,1
2008 (11) 18 10,4
2009 (14) 17 9,8
2010 (18) 21 12,1
2011 (21) 27 15,6
2012 (18) 27 15,6
2013 (November 30) (18) 33 19,1
TOTAL (119) 173 100
1B. Journal of publication Number of cases %
1. Neurology or Psychiatry 86 49,7
2. Internal or general medicine 34 19,6
3. Other Specialties 34 19,6
4. Gynecological, included Oncological Gynecology 19 11,0
TOTAL 173 100
1C. Country of birth or study Number of cases %
Africa: (Mauritania, France) 1 0,6
Asia: (Japan-38; Taiwan-4; Singapore-3, Hong-Kong-2; and 1 in China, India, S-Korea and Lebanon) 51 29,5
Australia: (Australia-9; New Zeland-4) 13 7,5
Europe: (Spain-7; UK-7; France-6; Germany-5; 3 in Netherlands, Belgium, Italy and Turkey; and 1 in Ireland and Greece) 39 22,5
North-America: (USA-47; Canada-4, Mexico-1) 52 30,1
Center and South-America: (1 in Brazil, Colombia and Jamaica) 3 1,7
Spain (Barcelona) v USA (Pennsylvania) 14 8,1
TOTAL 173 100